Michel Jourdan
Centre National de la Recherche Scientifique(FR)Centre Hospitalier Universitaire de Montpellier(FR)Institut de Génétique Humaine(FR)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Glycosylation and Glycoproteins Research, Immune Cell Function and Interaction, T-cell and B-cell Immunology, Immunotherapy and Immune Responses
Most-Cited Works
- → Interleukin-6 as a Therapeutic Target(2015)354 cited
- → An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization(2009)238 cited
- → Survival and Proliferation Factors of Normal and Malignant Plasma Cells(2003)211 cited
- → JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen‐activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells(2000)173 cited
- → Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays(2002)170 cited
- → The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor(2009)164 cited